Effect of St. John's Wort (Hypericum perforatum) treatment on restraint stress-induced behavioral and biochemical alteration in mice

BMC Complementary and Alternative Medicine

Volumn 10, Issue , 2010, Pages

  Kumar, Anil ^a   Garg, Ruchika ^a   Prakash, Atish K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; GLUTATHIONE; HYPERICUM PERFORATUM EXTRACT; MALONALDEHYDE; NITRITE; PROTEIN; ANTIOXIDANT; PLANT EXTRACT;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BRAIN; CONTROLLED STUDY; DRUG EFFECT; HYPERICUM PERFORATUM; IMMOBILIZATION STRESS; LOCOMOTION; MALE; MOUSE; NONHUMAN; OXIDATION; PAIN THRESHOLD; TAIL FLICK TEST; ANIMAL; ANIMAL BEHAVIOR; EXERCISE; HYPERICUM; MENTAL STRESS; METABOLISM; MOUSE STRAIN; OXIDATIVE STRESS; PHYTOTHERAPY; PSYCHOLOGICAL ASPECT;

ANIMALS; ANTIOXIDANTS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; CATALASE; GLUTATHIONE; HYPERICUM; LOCOMOTION; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED STRAINS; NITRITES; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

EID: 77951955522     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-10-18     Document Type: Article

References (46)

1. Jacobson L, Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamo- pituitary- adrenocortical axis. Endocr Rev 1991, 12:118-134. 10.1210/edrv-12-2-118, 2070776.
2. Sherki YG, Melemed E, Offen D. Oxidative stress induced- neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 2001, 40:959-975. 10.1016/S0028-3908(01)00019-3, 11406187.
3. Masood A, Banerjee BD, Vijayan VK, Ray A. Modulation of stress induced neurobehavioral changes by nitric oxide in rats. Eur J Pharmacol 2003, 458:138-9.
4. Masood A, Banerjee BD, Vijayan VK, Ray A. Pharmacological and biochemical studies on the possible role of nitric oxide in the stress adaptation in rats. Eur J Pharmacol 2004, 493:111-5. 10.1016/j.ejphar.2004.04.018, 15189771.
5. Ray A, Masood A, Banerjee BD, Vijayan VK. Nitric oxide: a target molecule for drug development in the stress and anxiety. Clin Exp Pharmacol Physiol 2004, 31:A51.
6. Liu J, Wang X, Mori A. Restraint stress-induced antioxidant defence changes in rat plasma, effect of treatment with reduced gluthione. Int J Biochem 1994, 26:511-517. 10.1016/0020-711X(94)90008-6, 8013736.
7. Liu J, Wang X, Shingenaga MK, Yeo HC, Mori A, Ames BN. Restraint stress causes oxidative damage to lipid, protein, and DNA in the brains of rats. FASEB J 1996, 10:1532-1538.
8. Halliwell B, Gutteridge JMC. Oxygen radicals and the nervous system. Trends Neurosci 1985, 8:22-6.
9. Bristow DJ, Holmes DS. Cortisol levels and anxiety related behaviours in cattle. Physiol Behav 2007, 90:626-628. 10.1016/j.physbeh.2006.11.015, 17196624.
10. Goyal R, Anil K. Protective effect of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations inmice. Pharmacol Rep 2007, 59:284-90.
11. Dhir A, Padi SV, Naidu PS, Kulkarni SK. Protective effect of Naproxen (non selective COX inhibitor) or rofecoxib (selective COX inhibitor) on restraint stress induced behavioral and biochemical alterations in mice. Eur J Pharmacol 2006, 535:192-8. 10.1016/j.ejphar.2006.01.064, 16522321.
12. Kumar A, Goyal R. Gabapentin attenuates acute hypoxic stress-induced behavioral alterations and oxidative damage in mice: possible involvement of GABAergic mechanism. Indian J Exp Biol 2008, 46:159-63.
13. Amir S, Amit Z. Endogenous opioid ligands may mediate stress-induced changes in the affective properties of pain related behavior in rats. Life Sci 1978, 23:1143-1152. 10.1016/0024-3205(78)90348-X, 713690.
14. Davis M, Shi C. The extended amygdala: are the central nucleus of amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety?. Ann NY Acad Sci 1999, 877:281-91. 10.1111/j.1749-6632.1999.tb09273.x, 10415655.
15. LeDoux J. Fear and the brain where have we been and where are we going?. Bio Psychiatry 1998, 44:1229-38.
16. Henke PG, Ray A. Stress ulcer modulation by limbic system structures. Acta Physiol Hung 1992, 80:117-25.
17. Honkaniemi J, Kainu T, Ceccatelli S, Rehardt L, Hokfelt T, Pelto-Huikko M. Fos and jun in rat central amygdaloid nucleus and paraventricular nucleus after stress. Neuro Report 1992, 3:849-52.
18. Vitiello B. Hypericum perforatum extracts as potential antidepressants. J Pharm Pharmacol 1999, 51:513-517. 10.1211/0022357991772781, 10411209.
19. Di Carlo G, Borelli F, Izzo AA. St. John's Wort: prozac from the plant kingdom. TIPS 2001, 22:292-7.
20. Gaster B, Holroyad J. St. John's Wort for depression. Arch Intern Med 2000, 160:152-6. 10.1001/archinte.160.2.152, 10647752.
21. Greenson JM, Sanford B, Monti DA. St. John's Wort (hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacol 2001, 153:402-14.
22. Lakmann G, Schule C, Baghai T, Kieser M. St. John's Wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 1998, 31:54-59. 10.1055/s-2007-979346, 9684948.
23. Kumar A, Singh A. Protective effect of St. John's wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice. Planta Med 2007, 73:1358-64. 10.1055/s-2007-990234, 17918039.
24. Sur TK, Bhattacharya D. The effect of Panax Ginseng and diazepam on brain and hypothalamic 5- hydroxytryptamine during stress. Indian J Pharmacol 1997, 29:318-321.
25. D'Amour EF, Smith DLA. Method for determines loss of pain sensation. J Pharmacol Exp Ther 1941, 72:74-79.
26. Kulkarni SK. Handbook of Experimental Pharmacology. Vallabh Prakashan 1999, 123-125.
27. Reddy DS, Kulkarni SK. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine- induced learning impairment. Brain Res 1998, 799:215-29. 10.1016/S0006-8993(98)00419-3, 9675286.
28. Wills ED. Mechanism of lipid peroxide formation in animal tissues. Biochem J 1966, 99:667-676. 1265056, 5964963.
29. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:48670-48677.
30. Green LC, Wagner DA, Glagowski J. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 1982, 126:131-138. 10.1016/0003-2697(82)90118-X, 7181105.
31. Lowry OH, Rosenberg NJ, Farr AL, Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem 1951, 193:265-275.
32. Luck H. Catalase. Methods of Enzymatic Analysis 1971, 885-893. Academic Press, New York, Bergmeyer HU.
33. Carrasco GA, VandeKar LD. Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003, 493:111-5.
34. McEwen BS. Protection and damage from acute and chronic stress. Ann NY Acad Sci 2004, 1032:1-7. 10.1196/annals.1314.001, 15677391.
35. Esch T, Fricchione GL, Stefano GB. The therapeutic use of the relaxation response in stress-related diseases. Med Sci Monit 2003, 9:RA 23-34.
36. Metz GA, Jadavji NM, Smith LK. Modulation of motor function by stress: a novel concept of the effects of stress and corticosterone on behavior. Eur J Neurosci 2005, 22:1190-200. 10.1111/j.1460-9568.2005.04285.x, 16176362.
37. Torres IL, Vasconcellos AP, Silveira Cucco SN, Dalmaz C. Effect of repeated stress on novelty-induced antinociception in rats. Braz J Med Biol Res 2001, 34:241-4.
38. Sevgi S, Ozek M, Eroglu L. L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress. Methods Find Exp Clin Pharmacol 2006, 28:95-9. 10.1358/mf.2006.28.2.977840, 16636719.
39. Freire-Garabal M, Nunez MJ, Losada C, Periro D, Reveiro MP, Gonzailez-Patino E, Mayan JM, ReyMendez M. Effects of fluoxetine on immunosuppressive response to stress in mice. Life Sci 1997, 60:403-413. 10.1016/S0024-3205(97)00329-9, 9031687.
40. Wicher MC, Barge-Schaapveld DQ, Nicolson NA, Peeters F, De Vries M, Mengelers R, Van Os J. Reduced Stress-Sensitivity or Increased Reward Experience: The Psychological Mechanism of Response to Antidepressant Medication. Neuropsychopharmacol 2009, 34(4):923-31.
41. Marzatico F, Bertorelli L, Pansarasa O, Guallini P, Torri C, Biagini G. Brain oxidative damage following acute immobilization and mild emotional stress. International J Stress Management 1998, 5(4):223-36.
42. Hong W, Suh Dong K, Song Sung O, Huh Yung H. Involvement of dynorphin in restraint stress-induced antinociception in the mouse. Eur Neuropsychopharmacol 2000, 10:407-413.
43. Tsuboi H, Tatsumi A, Yamamoto K, Kobayashi F, Shimo K, Kinae N. Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. J Affect Disord 2006, 91:63-70. 10.1016/j.jad.2005.12.010, 16430969.
44. Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004, 19:89-95. 10.1097/00004850-200403000-00006, 15076017.
45. Zafir A, Banu N. Antioxidant potential of fluxetine in comparison to curcuma longa in restraint-stressed rats. Euro J Pharmacol 2007, 572:23-31.
46. Kolla N, Wei Z, Richardson JS, Li XM. Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide. J Psychiatry Neurodci 2005, 30(3):196-201.